Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Hogan

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Journal of the American Society of Nephrology : JASN|July 31, 2004
Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritisJia Jin Yang, William F Pendergraft, David A Alcorta, et al.
Journal of Clinical Pharmacology|June 9, 2022
The Impact of Suboptimal 25-Hydroxyvitamin D Levels and Cholecalciferol Replacement on the Pharmacokinetics of Oral Midazolam in Control Subjects and Patients With Chronic Kidney DiseaseStacey M Tuey, Linda Prebehalla, Amandla-Atilano Roque, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control studySusan L Hogan, Glinda S Cooper, David A Savitz, et al.
Journal of the American Society of Nephrology : JASN|August 15, 2008
Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitisDavid J Bautz, Gloria A Preston, Sofia Lionaki, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 1, 2014
Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failureTaewoo Lee, Adil Gasim, Vimal K Derebail, et al.
Kidney International Reports|June 25, 2021
Association of Lupus Nephritis Histopathologic Classification With Venous Thromboembolism-Modification by Age at BiopsyIan Cooley, Vimal K Derebail, Keisha L Gibson, et al.
Kidney International|July 4, 2008
ANCA patients have T cells responsive to complementary PR-3 antigenJiajin Yang, David J Bautz, Sofia Lionaki, et al.
Kidney International Reports|January 1, 2020
Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody VasculitisCarmen E Mendoza, Elizabeth J Brant, Matthew L McDermott, et al.
European Journal of Clinical Pharmacology|September 17, 2018
Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patientsMustafa E Ibrahim, Cara Chang, Yichun Hu, et al.
Journal of the American Society of Nephrology : JASN|July 25, 2008
Maintenance of tolerance by regulation of anti-myeloperoxidase B cellsDonna O Bunch, Jonathan S Silver, Melanie C Majure, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Journal of the American Society of Nephrology : JASN|July 31, 2004
Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritisJia Jin Yang, William F Pendergraft, David A Alcorta, et al.
Journal of Clinical Pharmacology|June 9, 2022
The Impact of Suboptimal 25-Hydroxyvitamin D Levels and Cholecalciferol Replacement on the Pharmacokinetics of Oral Midazolam in Control Subjects and Patients With Chronic Kidney DiseaseStacey M Tuey, Linda Prebehalla, Amandla-Atilano Roque, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control studySusan L Hogan, Glinda S Cooper, David A Savitz, et al.
Journal of the American Society of Nephrology : JASN|August 15, 2008
Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitisDavid J Bautz, Gloria A Preston, Sofia Lionaki, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 1, 2014
Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failureTaewoo Lee, Adil Gasim, Vimal K Derebail, et al.
Kidney International Reports|June 25, 2021
Association of Lupus Nephritis Histopathologic Classification With Venous Thromboembolism-Modification by Age at BiopsyIan Cooley, Vimal K Derebail, Keisha L Gibson, et al.
Kidney International|July 4, 2008
ANCA patients have T cells responsive to complementary PR-3 antigenJiajin Yang, David J Bautz, Sofia Lionaki, et al.
Kidney International Reports|January 1, 2020
Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody VasculitisCarmen E Mendoza, Elizabeth J Brant, Matthew L McDermott, et al.
European Journal of Clinical Pharmacology|September 17, 2018
Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patientsMustafa E Ibrahim, Cara Chang, Yichun Hu, et al.
Journal of the American Society of Nephrology : JASN|July 25, 2008
Maintenance of tolerance by regulation of anti-myeloperoxidase B cellsDonna O Bunch, Jonathan S Silver, Melanie C Majure, et al.
Pageof 14